Clinical Trials Browser

Phase 3 × Eflornithine × Dermatologic × Clear all

NCT00005884 2019-12-13

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

Phase 3 Completed

Carcinoma, Basal Cell